XML 32 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021   42,338,898      
Beginning balance at Dec. 31, 2021 $ 271,786 $ 5 $ 389,408 $ (560) $ (117,067)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options and purchases pursuant to employee stock purchase plan (in shares)   51,688      
Exercise of stock options and purchases pursuant to employee stock purchase plan 171   171    
Stock-based compensation expense 6,462   6,462    
Unrealized gain (loss) on investments (317)     (317)  
Net loss $ (101,945)       (101,945)
Ending balance (in shares) at Dec. 31, 2022 42,390,586 42,390,586      
Ending balance at Dec. 31, 2022 $ 176,157 $ 5 396,041 (877) (219,012)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options and purchases pursuant to employee stock purchase plan (in shares)   158,274      
Exercise of stock options and purchases pursuant to employee stock purchase plan 499   499    
Issuance of common stock upon initial public offering, net of issuance cost (in shares)   4,651,163      
Proceeds from sale of common stock and pre-funded warrants, net of issuance cost 47,580   47,580    
Stock-based compensation expense 6,939   6,939    
Issuance of common stock upon settlement of restricted stock units (in shares)   77,312      
Taxes paid related to net share settlement of equity awards (in shares)   (17,227)      
Taxes paid related to net share settlement of equity awards (53)   (53)    
Unrealized gain (loss) on investments 881     881  
Net loss $ (87,298)       (87,298)
Ending balance (in shares) at Dec. 31, 2023 47,260,108 47,260,108      
Ending balance at Dec. 31, 2023 $ 144,705 $ 5 $ 451,006 $ 4 $ (306,310)